posted on 2014-04-15, 00:00authored byPing Zhou, Sarah C. Baumgarten, Yanguang Wu, Jill Bennett, Nicola Winston, Jennifer Hirshfeld-Cytron, Carlos Stocco
FSH and IGF-I synergistically stimulate gonadal steroid production; conversely, silencing the FSH or
the IGF-I genes leads to infertility and hypogonadism. To determine the molecular link between
these hormones, we examined the signaling cross talk downstream of their receptors. In human
and rodent granulosa cells (GCs), IGF-I potentiated the stimulatory effects of FSH and cAMP on the
expression of steroidogenic genes. In contrast, inhibition of IGF-I receptor (IGF-IR) activity or
expression using pharmacological, genetic, or biochemical approaches prevented the FSH- and
cAMP-induced expression of steroidogenic genes and estradiol production. In vivo experiments
demonstrated that IGF-IR inactivation reduces the stimulation of steroidogenic genes and follicle
growth by gonadotropins. FSH or IGF-I alone stimulated protein kinase B (PKB), which is also
known as AKT and in combination synergistically increased AKT phosphorylation. Remarkably,
blocking IGF-IR expression or activity decreased AKT basal activity and abolished AKT activation by
FSH. In GCs lacking IGF-IR activity, FSH stimulation of Cyp19 expression was rescued by overexpression
of constitutively active AKT. Our findings demonstrate, for the first time, that in human,
mouse, and rat GCs, the well-known stimulatory effect of FSH on Cyp19 and AKT depends on IGF-I
and on the expression and activation of the IGF-IR.
Funding
This work was supported by National Institutes of Health
Grants R01HD057110 and R21HD066233.